Britannia Life Sciences (FRA:L020) Total Liabilities : €10.95 Mil (As of Dec. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Britannia Life Sciences Total Liabilities?

Britannia Life Sciences's Total Liabilities for the quarter that ended in Dec. 2024 was €10.95 Mil.

Britannia Life Sciences's quarterly Total Liabilities increased from Jun. 2024 (€10.51 Mil) to Sep. 2024 (€11.00 Mil) but then declined from Sep. 2024 (€11.00 Mil) to Dec. 2024 (€10.95 Mil).

Britannia Life Sciences's annual Total Liabilities declined from Mar. 2022 (€11.19 Mil) to Mar. 2023 (€8.52 Mil) but then increased from Mar. 2023 (€8.52 Mil) to Mar. 2024 (€10.60 Mil).

Britannia Life Sciences Total Liabilities Historical Data

The historical data trend for Britannia Life Sciences's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Britannia Life Sciences Total Liabilities Chart

Britannia Life Sciences Annual Data

Trend

Mar21

Mar22

Mar23

Mar24

Total Liabilities

12.56

11.19

8.52

10.60

Britannia Life Sciences Quarterly Data
	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Total Liabilities	Get a 7-Day Free Trial													7.56	10.60	10.51	11.00	10.95

Britannia Life Sciences Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Britannia Life Sciences's Total Liabilities for the fiscal year that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	7.138	+	(3.439	+	-4.2674197509029E-16
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0.02	+	0	+	0)
	=	10.60

Total Liabilities	=	Total Assets (A: Mar. 2024 )	-	Total Equity (A: Mar. 2024 )
	=	15.131	-	4.534
	=	10.60

Britannia Life Sciences's Total Liabilities for the quarter that ended in Dec. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	7.812	+	(3.115	+	-9.3675067702748E-17
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit	+	NonCurrent Deferred Income Tax)
	+	0.021	+	0	+	0)
	=	10.95

Total Liabilities	=	Total Assets (Q: Dec. 2024 )	-	Total Equity (Q: Dec. 2024 )
	=	14.859	-	3.911
	=	10.95

Britannia Life Sciences Total Liabilities Related Terms

Thank you for viewing the detailed overview of Britannia Life Sciences's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Britannia Life Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Britannia Life Sciences Inc (FRA:L020) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

BLSIF:USA BLAB:Canada

Address

120 Adelaide Street West, Suite 2400, Toronto, ON, CAN, M5H 1T1

Website

https://www.britannia.life

Britannia Life Sciences Inc provides product testing, safety assessment and compliance services to the cosmetic, consumer packaged goods and nutraceutical industries in the United Kingdom and globally.

Britannia Life Sciences Headlines

No Headlines